Siobhan Crowley

TL;DR: A public-health approach to antiretroviral therapy (ART) to enable scaling-up access to treatment for HIV-positive people in developing countries, recognising that the western model of specialist physician management and advanced laboratory monitoring is not feasible in resource-poor settings.

TL;DR: This review examines HAART as a potential tool for preventing HIV transmission and recommends further evaluation of human rights and ethical considerations, clarification of research priorities and exploration of feasibility and acceptability issues.

TL;DR: Increasing the provision of ART to <350 cells/mm3 may significantly reduce costs while reducing the HIV burden, and sensitivity analyses suggest that poor retention and predominant acute phase transmission reduce DALYs averted by 26% and savings by 7%.

TL;DR: Building on previous modelling work, an HIV/AIDS epidemic of South African intensity is used to explore the impact of testing all adults annually and starting persons on HAART immediately after they are diagnosed as HIV positive, which would reduce annual HIV incidence and mortality to less than one case per 1000 people within 10 years and it would reduce the prevalence of HIV toLess than 1% within 50 years.

TL;DR: A meeting was convened to review recommendations by WHO for the diagnostic testing of HIV infection in infants and children, and the new recommendations for antiretroviral therapy (ART) are included.